-
公开(公告)号:AU2016282289A1
公开(公告)日:2018-01-04
申请号:AU2016282289
申请日:2016-06-23
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , PATEL NARENDRA KUMAR B , PAULS HEINZ W , LI SZE-WAN , NG GRACE , LAUFER RADOSLAW , LIU YONG , LANG YUNHUI
IPC: C07D495/04 , A61K31/4436 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/551 , A61K39/395 , A61P35/00
Abstract: Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X
-
公开(公告)号:SMT201600430B
公开(公告)日:2017-01-10
申请号:SM201600430
申请日:2016-11-24
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , LIU YONG , LI SZE-WAN , FORREST BRYAN T , PAULS HEINZ W , EDWARDS LOUISE G , FEHER MIKLOS , PATEL NARENDRA KUMAR B , LAUFER RADOSLAW , PAN GUOHUA
-
公开(公告)号:MX2016004963A
公开(公告)日:2016-06-28
申请号:MX2016004963
申请日:2014-10-17
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , PAULS HEINZ W , FEHER MIKLOS
IPC: C07D413/14 , A61K31/5377 , A61P35/00
Abstract: Se describe una sal fumarato y una sal maleato del compuesto (I) representado por la siguiente fórmula estructural, así como sus composiciones farmacéuticas correspondientes; las formas particulares cristalinas sencillas del compuesto (I) fumarato y el compuesto (I) maleato 1:1 se caracterizan por una variedad de propiedades y mediciones físicas; también se describen métodos de preparación de formas específicas cristalinas del compuesto (I) fumarato 1:1 y el compuesto (I) maleato; la presente invención también proporciona métodos de tratamiento de un sujeto con un cáncer. (ver Fórmula).
-
公开(公告)号:SG11201603102TA
公开(公告)日:2016-05-30
申请号:SG11201603102T
申请日:2014-11-14
Applicant: UNIV HEALTH NETWORK
Inventor: LAUFER RADOSLAW , NG GRACE , LI SZE-WAN , PAULS HEINZ W , LIU YONG , PATEL NARENDRA KUMAR B
IPC: C07D487/04 , A61K31/519 , A61P35/00
Abstract: The present teachings provide a compound represented by the following structural formula: (Formula (I)); or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
-
公开(公告)号:EA023173B1
公开(公告)日:2016-04-29
申请号:EA201270752
申请日:2011-04-06
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , LIU YONG , LI SZE-WAN , FORREST BRYAN T , PAULS HEINZ W , EDWARDS LOUISE G , FEHER MIKLOS , PATEL NARENDRA KUMAR B , LAUFER RADOSLAW , PAN GUOHUA
IPC: C07D413/14 , A61K31/5377 , A61P35/00 , C07D403/04
Abstract: Изобретениеотноситсяк соединению, представленномуследующейструктурнойформулой, иегофармацевтическиприемлемымсолям:Указанныесоединенияявляютсяингибиторами polo-подобныхкиназ 4 (PLK4) и Aurora кинази могутбытьиспользованыдлялечениязлокачественнойопухоли.
-
公开(公告)号:AU2013344716A1
公开(公告)日:2015-05-14
申请号:AU2013344716
申请日:2013-11-15
Applicant: UNIV HEALTH NETWORK
Inventor: LIU YONG , PAULS HEINZ W , LAUFER RADOSLAW , LI SZE-WAN , SAMPSON PETER BRENT , FEHER MIKLOS , NG GRACE , PATEL NARENDRA KUMAR B , LANG YUNHUI
IPC: C07D487/04 , A61K31/519 , A61P35/00
Abstract: The present teachings provide a compound represented by structural formula (1-0), or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
-
公开(公告)号:AU2011238384B2
公开(公告)日:2015-02-19
申请号:AU2011238384
申请日:2011-04-06
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , LIU YONG , LI SZE-WAN , FORREST BRYAN T , PAULS HEINZ W , EDWARDS LOUISE G , FEHER MIKLOS , PATEL NARENDRA KUMAR B , LAUFER RADOSLAW , PAN GUOHUA
IPC: C07D403/04 , A61K31/5377 , A61P35/00 , C07D413/14
Abstract: The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: (I). Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
-
公开(公告)号:AU2008340991B2
公开(公告)日:2012-02-23
申请号:AU2008340991
申请日:2008-12-19
Applicant: UNIV HEALTH NETWORK
Inventor: PAN GUOHUA , FORREST BRYAN T , LAUFER RADOSLAW , FEHER MIKLOS , PAULS HEINZ W , SAMPSON PETER BRENT , LI SZE-WAN , LIU YONG
IPC: C07D401/14 , A61K31/416 , A61K31/4192 , A61P35/00 , C07D403/06 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , C07D513/04
Abstract: The present invention is directed to a compound is represented by Structural Formula (A):or a pharmaceutically acceptable salt therof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:AU2008340991A1
公开(公告)日:2009-07-02
申请号:AU2008340991
申请日:2008-12-19
Applicant: UNIV HEALTH NETWORK
Inventor: PAN GUOHUA , FORREST BRYAN T , LAUFER RADOSLAW , FEHER MIKLOS , PAULS HEINZ W , SAMPSON PETER BRENT , LI SZE-WAN , LIU YONG
IPC: C07D401/14 , A61K31/416 , A61K31/4192 , A61P35/00 , C07D403/06 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , C07D513/04
Abstract: The present invention is directed to a compound is represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The present invention is also directed to a pharmaceutical composition comprising a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject having cancer, wherein the method comprises administering a therapeutically effective amount of a compound represented by Structural Formula (A) described above or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:PL3322711T3
公开(公告)日:2021-10-25
申请号:PL16813437
申请日:2016-06-23
Applicant: UNIV HEALTH NETWORK
Inventor: SAMPSON PETER BRENT , PATEL NARENDRA KUMAR B , PAULS HEINZ W , LI SZE-WAN , NG GRACE , LAUFER RADOSLAW , LIU YONG , LANG YUNHUI
IPC: C07D495/04 , A61K31/4355 , A61K31/4436 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/5355 , A61K31/5377 , A61K31/551 , A61K39/00 , A61K39/395 , A61K45/06 , A61P35/00 , C07K16/28
-
-
-
-
-
-
-
-
-